SAM
DGX icon

Smartleaf Asset Management’s Quest Diagnostics DGX Stock Holding History

Smartleaf Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Sell
1,120
-22
-2% -$4.27K 0.01% 753
2025
Q4 		$200K Buy
1,142
+236
+26% +$43K 0.01% 798
2025
Q3 		$171K Buy
906
+234
+35% +$41.5K 0.01% 791
2025
Q2 		$120K Sell
672
-180
-21% -$31.3K 0.01% 797
2025
Q1 		$143K Buy
852
+110
+15% +$18.1K 0.01% 689
2024
Q4 		$112K Buy
742
+110
+17% +$17.1K 0.01% 794
2024
Q3 		$97.9K Buy
632
+268
+74% +$40K 0.01% 714
2024
Q2 		$50K Buy
364
+53
+17% +$7.26K 0.01% 741
2024
Q1 		$40.8K Buy
311
+227
+270% +$29.5K 0.01% 723
2023
Q4 		$11.6K Buy
+84
New +$11K ﹤0.01% 744

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Smartleaf Asset Management's DGX Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Quest Diagnostics (DGX) stake by 1.9% in Q1 2026, selling an estimated $4.27K and leaving 1,120 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #753.

Smartleaf Asset Management first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Smartleaf Asset Management held 1,120 shares of Quest Diagnostics worth $221K as of Q1 2026.
  • Smartleaf Asset Management sold 22 Quest Diagnostics shares in Q1 2026, an estimated $4.27K.
  • Quest Diagnostics made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #753 holding.
  • Smartleaf Asset Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.